Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
First isolated and characterized in the early 1990s, this 15-amino acid peptide has garnered significant attention in preclinical research for its remarkable cytoprotective and regenerative properties across multiple organ systems
CIRULLI M
Hikma Pharmaceuticals Hikma is working on generic versions and biosimilars of GLP-1 drugs to improve accessibility and affordability in developing markets
Quantification of the contribution of GLP-1 to mediating insulinotropic effects of DPP-4 inhibition with vildagliptin in healthy subjects and patients with type 2 diabetes using exendin [939] as a GLP-1 receptor antagonist
US$ 23.29
US$ 26.90
US$ 21.63
US$ 23.49
US$ 24.98
US$ 21.12
